Use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease
Neurology Minute · American Academy of Neurology
July 9, 20191m 38s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Dr. Franziska Hopfner talks about the main takeaways from her paper on the use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease.